Experimental models of membranoproliferative glomerulonephritis, including dense deposit disease

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 198-210

  Vernon, Katherine A ^a   Pickering, Matthew C ^a   Cook, H Terence ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H;

ANIMAL; ARTICLE; DISEASE MODEL; DOG; HUMAN; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SWINE;

ANIMALS; COMPLEMENT C3; COMPLEMENT C5; COMPLEMENT FACTOR H; DISEASE MODELS, ANIMAL; DOGS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; MICE; SWINE;

EID: 79551489396     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314775     Document Type: Article

References (58)

1. Cork LC, Morris JM, Olson JL, Krakowka S, Swift AJ, Winkelstein JA: Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complement. Clin Immunol Immunopathol 1991;60:455-470.
2. Frelier PF, Pritchard J, Armstrong DL, Nagge WT, Lewis RM: Spontaneous mesangiocapillary glomerulonephritis in Finn cross lambs from Alberta. Can J Comp Med 1984;48:215-218.
3. Sabnis SG, Gunson DE, Antonovych TT: Some unusual features of mesangioproliferative glomerulonephritis in horses. Vet Pathol 1984;21:574-581.
4. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M: Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 1995;95:1054-1061.
5. Johnson JP, McLean RH, Cork LC, Winkelstein JA: Genetic analysis of an inherited deficiency of the third component of complement in Brittany spaniel dogs. Am J Med Genet 1986;25:557-562.
6. Winkelstein JA, Cork LC, Griffin DE, Griffin JW, Adams RJ, Price DL: Genetically determined deficiency of the third component of complement in the dog. Science 1981;212:1169-1170.
7. Winkelstein JA, Johnson JP, Swift AJ, Ferry F, Yolken R, Cork LC: Genetically determined deficiency of the third component of complement in the dog: in vitro studies on the complement system and complement- mediated serum activities. J Immunol 1982;129:2598-2602.
8. Nuttall W: New sheep breeds bring new diseases. Surveillance 1991;18:23-24.
9. Angus KW, Sykes AR, Gardiner AC, Morgan KT, Thomson D: Mesangiocapillary glomerulonephritis in lambs. I. Clinical and biochemical findings in a Finnish Landrace flock. J Comp Pathol 1974;84:309-317.
10. Young GB, Sales DI, Waddington D, Angus KW, Gardiner AC: Genetic aspects of mesangiocapillary glomerulonephritis in Finnish sheep. Br Vet J 1981;137:368-373.
11. Botto M, Walport MJ: Hereditary deficiency of C3 in animals and humans. Int Rev Immunol 1993;10:37-50.
12. Steinsson K, Erlendsson K, Valdimarsson H: Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythematosus: clinical experience over forty- five months. Arthritis Rheum 1989;32:906-913.
13. Taneda S, Hudkins KL, Cui Y, Farr AG, Alpers CE, Segerer S: Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 2003;63:576-590.
14. Taneda S, Hudkins KL, Muhlfeld AS, Kowalewska J, Pippin JW, Shankland SJ, Alpers CE: Protease nexin- 1, tPA, and PAI- 1 are upregulated in cryoglobulinemic membranoproliferative glomerulonephritis. J Am Soc Nephrol 2008;19:243-251.
15. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 2001;159:2355-2369.
16. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A: A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 1994;22:321-328.
17. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, Friend SL, Farr A, Bedell MA, Jenkins NA, Copeland NG, Grabstein K, Paxton RJ: Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000;192:671-680.
18. Funabiki K, Horikoshi S, Tomino Y, Nagai Y, Koide H: Immunohistochemical analysis of extracellular components in the glomerular sclerosis of patients with glomerulonephritis. Clin Nephrol 1990;34:239-246.
19. Oomura A, Nakamura T, Arakawa M, Ooshima A, Isemura M: Alterations in the extracellular matrix components in human glomerular diseases. Virchows Arch A Pathol Anat Histopathol 1989;415:151-159.
20. Eddy AA: Plasminogen activator inhibitor- 1 and the kidney. Am J Physiol Renal Physiol 2002;283:F209-F220.
21. Fogo AB: Renal fibrosis: not just PAI- 1 in the sky. J Clin Invest 2003;112:326-328.
22. Huang Y, Noble N: An unexpected role of plasminogen activator inhibitor- type 1 (PAI- 1) in renal fibrosis. Kidney Int 2005;67:2502-2503.
23. Guo S, Muhlfeld AS, Wietecha TA, Peutz- Kootstra CJ, Kowalewska J, Yi K, Spencer M, Pichaiwong W, Nimmerjahn F, Hudkins KL, Alpers CE: Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemiaassociated membranoproliferative glomerulonephritis. Am J Pathol 2009;175:107-118.
24. Muhlfeld AS, Segerer S, Hudkins K, Carling MD, Wen M, Farr AG, Ravetch JV, Alpers CE: Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 2003;163:1127-1136.
25. Muhlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE: Overexpression of complement inhibitor Crry does not prevent cryoglobulin- associated membranoproliferative glomerulonephritis. Kidney Int 2004;65:1214-1223.
26. Segerer S, Hudkins KL, Taneda S, Wen M, Cui Y, Segerer M, Farr AG, Alpers CE: Oral interferon- alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis 2002;39:876-888.
27. Iyoda M, Hudkins KL, Becker- Herman S, Wietecha TA, Banas MC, Guo S, Meyer- Bahlburg A, Kowalewska J, Liu G, Ziegler SF, Rawlings DJ, Alpers CE: Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J Am Soc Nephrol 2009;20:68-77.
28. Iyoda M, Hudkins KL, Wietecha TA, Banas MC, Guo S, Liu G, Wang L, Kowalewska J, Alpers CE: All- transretinoic acid aggravates cryoglobulinassociated membranoproliferative glomerulonephritis in mice. Nephrol Dial Transplant 2007;22:3451-3461.
29. Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH: Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ- lpr/lpr mice. J Immunol 1987;138:3785-3792.
30. Kikuchi S, Pastore Y, Fossati- Jimack L, Kuroki A, Yoshida H, Fulpius T, Araki K, Takahashi S, Lemoine R, Reininger L, Izui S: A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia. J Immunol 2002;169:4644-4650.
31. Trendelenburg M, Fossati- Jimack L, Cortes- Hernandez J, Turnberg D, Lewis M, Izui S, Cook HT, Botto M: The role of complement in cryoglobulin- induced immune complex glomerulonephritis. J Immunol 2005;175:6909-6914.
32. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J: Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long- term prognosis. Am J Med 1983;74:175-192.
33. Daha MR, Fearon DT, Austen KF: C3 Nephritic factor (C3NeF): stabilization of fluid phase and cell- bound alternative pathway convertase. J Immunol 1976;116:1-7.
34. Linshaw MA, Stapleton FB, Cuppage FE, Forristal J, West CD, Schreiber RD, Wilson CB: Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3. Am J Nephrol 1987;7:470-477.
35. Marder HK, Coleman TH, Forristal J, Beischel L, West CD: An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis. Kidney Int 1983;23:749-758.
36. Meri S, Koistinen V, Miettinen A, Tornroth T, Seppala IJ: Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med 1992;175:939-950.
37. Licht C, Heinen S, Jozsi M, Loschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, Kirschfink M, Hoppe B, Zipfel PF: Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 2006;70:42-50.
38. Levy M, Halbwachs- Mecarelli L, Gubler MC, Kohout G, Bensenouci A, Niaudet P, Hauptmann G, Lesavre P: H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 1986;30: 949-956.
39. Lopez- Larrea C, Dieguez MA, Enguix A, Dominguez O, Marin B, Gomez E: A familial deficiency of complement factor H. Biochem Soc Trans 1987;15:648-649.
40. Hegasy GA, Manuelian T, Hogasen K, Jansen JH, Zipfel PF: The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. Am J Pathol 2002;161:2027-2034.
41. Hogasen K, Jansen JH, Harboe M: Eradication of porcine factor H deficiency in Norway. Vet Rec 1997;140:392-395.
42. Jansen JH, Hogasen K, Grondahl AM: Porcine membranoproliferative glomerulonephritis type II: an autosomal recessive deficiency of factor H. Vet Rec 1995;137:240-244.
43. Jansen JH, Hogasen K, Harboe M, Hovig T: In situ complement activation in porcine membranoproliferative glomerulonephritis type II. Kidney Int 1998;53:331-349.
44. Jansen JH, Hogasen K, Mollnes TE: Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease). Am J Pathol 1993;143:1356-1365.
45. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M: Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 1995;95:1054-1061.
46. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002;31:424-428.
47. Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, Cook HT, Botto M: Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H- deficient mice. Proc Natl Acad Sci USA 2006;103:9649-9654.
48. Alexander JJ, Wang Y, Chang A, Jacob A, Minto AW, Karmegam M, Haas M, Quigg RJ: Mouse podocyte complement factor H: the functional analog to human complement receptor 1. J Am Soc Nephrol 2007;18:1157-1166.
49. Rose KL, Paixao- Cavalcante D, Fish J, Manderson AP, Malik TH, Bygrave AE, Lin T, Sacks SH, Walport MJ, Cook HT, Botto M, Pickering MC: Factor I is required for the development of membranoproliferative glomerulonephritis in factor H- deficient mice. J Clin Invest 2008;118:608-618.
50. Amadei N, Baracho GV, Nudelman V, Bastos W, Florido MP, Isaac L: Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H. Scand J Immunol 2001;53:615-621.
51. Genel F, Sjoholm AG, Skattum L, Truedsson L: Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis. Scand J Infect Dis 2005;37:615-618.
52. Sadallah S, Gudat F, Laissue JA, Spath PJ, Schifferli JA: Glomerulonephritis in a patient with complement factor I deficiency. Am J Kidney Dis 1999;33:1153-1157.
53. Vyse TJ, Spath PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ: Hereditary complement factor I deficiency. QJM 1994;87:385-401.
54. Habib R, Gubler MC, Loirat C, Maiz HB, Levy M: Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int 1975;7:204-215.
55. Vargas R, Thomson KJ, Wilson D, Cameron JS, Turner DR, Gill D, Chantler C, Ogg CS: Mesangiocapillary glomerulonephritis with dense deposits in the basement membranes of the kidney. Clin Nephrol 1976;5:73-82.
56. Walker PD, Ferrario F, Joh K, Bonsib SM: Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 2007;20:605-616.
57. Andresdottir MB, Assmann KJ, Hoitsma AJ, Koene RA, Wetzels JF: Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome. Nephrol Dial Transplant 1999;14:1723-1731.
58. West CD, Witte DP, McAdams AJ: Composition of nephritic factorgenerated glomerular deposits in membranoproliferative glomerulonephritis type 2. Am J Kidney Dis 2001;37:1120-1130.